LSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality

Dolder, Patrick C, Schmid, Yasmin, Müller, Felix, Borgwardt, Stefan, Liechti, Matthias E·2016·Neuropsychopharmacology

Cited by (246)

Items 101–200 of 246

  1. The Effects of Tryptamine Psychedelics in the Brain: A meta-Analysis of Functional and Review of Molecular Imaging Studies
    João Castelhano, Gisela Lima, Marta Teixeira, Carla Soares, Marta Lapo Pais, Miguel S. Castelo-Branco · 2021 · Frontiers in Pharmacology
  2. Dosing Psychedelics and MDMA
    Matthias E. Liechti, Friederike Holze · 2021 · Current topics in behavioral neurosciences
  3. Psychedelics in the treatment of unipolar and bipolar depression
    Oliver Gero Bosch, Simon Halm, Erich Seifritz · 2022 · International Journal of Bipolar Disorders
  4. How do serotonergic psychedelics treat depression: The potential role of neuroplasticity
    Artin, Hewa, Zisook, Sidney, Ramanathan, Dhakshin · 2021 · World Journal of Psychiatry
  5. Development and validation of an LC ‐ MS / MS method to quantify lysergic acid diethylamide ( LSD ), iso‐ LSD , 2‐oxo‐3‐hydroxy‐ LSD , and nor‐ LSD and identify novel metabolites in plasma samples in a controlled clinical trial
    Patrick C. Dolder, Matthias E. Liechti, Katharina Rentsch · 2017 · Journal of Clinical Laboratory Analysis
  6. LSD and ketanserin and their impact on the human autonomic nervous system
    Sebastian Olbrich, Katrin H. Preller, Franz X. Vollenweider · 2021 · Psychophysiology
  7. Analysis of recreational psychedelic substance use experiences classified by substance
    Adrian Hase, Max Erdmann, Verena Limbach, Gregor Hasler · 2022 · Psychopharmacology
  8. Psychedelic Cognition—The Unreached Frontier of Psychedelic Science
    Maria Bălăeţ · 2022 · Frontiers in Neuroscience
  9. The relationship between the default mode network and the theory of mind network as revealed by psychedelics – A meta-analysis
    Carla Soares, Gerardo Gonzalo Mier, João Castelhano, Miguel S. Castelo-Branco · 2023 · Neuroscience & Biobehavioral Reviews
  10. Large-scale brain connectivity changes following the administration of lysergic acid diethylamide, d-amphetamine, and 3,4-methylenedioxyamphetamine
    Mihai Avram, Lydia Fortea, Lea Wollner, Ricarda Coenen, Alexandra I. Korda, Helena Victoria Rogg, Friederike Holze, Patrick Vizeli, Laura Ley, Joaquim Raduà et al. · 2024 · Molecular Psychiatry
  11. The effect of psilocybin on empathy and prosocial behavior: a proposed mechanism for enduring antidepressant effects
    Kush V. Bhatt, Cory R. Weissman · 2024 · npj Mental Health Research
  12. Animal Behavior in Psychedelic Research
    Anna U. Odland, Jesper Langgaard Kristensen, Jesper Tobias Andreasen · 2022 · Pharmacological Reviews
  13. Acute serotonin 2A receptor activation impairs behavioral flexibility in mice
    Dionisio A. Amodeo, Omron Hassan, Landon M. Klein, Adam L. Halberstadt, Susan B. Powell · 2020 · Behavioural Brain Research
  14. Tripping over the other: Could psychedelics increase empathy?
    Emily Blatchford, Stephen Jason Bright, Liam B. Engel · 2020 · Journal of Evolutionary Psychology
  15. Can psychedelics enhance group psychotherapy? A discussion on the therapeutic factors
    Polina Ponomarenko, Federico Seragnoli, Abigail E. Calder, Peter Oehen, Gregor Hasler · 2023 · Journal of Psychopharmacology
  16. Psychedelics and sexual functioning: a mixed-methods study
    Tommaso Barba, Hannes Kettner, Caterina Radu, Joseph M. Peill, Leor Roseman, David Nutt, David Erritzøe, Robin Lester Carhart-Harris, Bruna Giribaldi · 2024 · Scientific Reports
  17. Pharmacokinetics and subjective effects of 1P‐LSD in humans after oral and intravenous administration
    Christina Grumann, Kerstin Henkel, Simon D. Brandt, Alexander Stratford, Torsten Passie, Volker Auwärter · 2020 · Drug Testing and Analysis
  18. Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA)
    Adam L. Halberstadt, Landon M. Klein, Muhammad Chatha, Laura B. Valenzuela, Alexander Stratford, Jason V. Wallach, David E. Nichols, Simon D. Brandt · 2018 · Psychopharmacology
  19. The impact of social media addiction on the negative emotions of adolescent athletes: the mediating role of physical appearance comparisons and sleep
    Weilong Lin, Zhenyu Cen, Ying Chen · 2025 · Frontiers in Public Health
  20. Psychedelic drugs for psychiatric disorders
    Sabrina Corrêa da Costa, Tyler Oesterle, Teresa A. Rummans, Elliott Richelson, Mark S. Gold · 2022 · Journal of the Neurological Sciences
  21. Self-transcendent experiences as promoters of ecological wellbeing? Exploration of the evidence and hypotheses to be tested
    Amy Isham, Patrick Elf, Tim P. Jackson · 2022 · Frontiers in Psychology
  22. New Psychoactive Substances: Major Groups, Laboratory Testing Challenges, Public Health Concerns, and Community-Based Solutions
    Chinaza Godswill Awuchi, Patrick Maduabuchi Aja, Nancy Bonareri Mitaki, Sonia Morya, Ikechukwu Otuosorochi Amagwula, Chinelo Kate Echeta, Victory S. Igwe · 2023 · Journal of Chemistry
  23. Low-dose LSD and the stream of thought: Increased Discontinuity of Mind, Deep Thoughts and abstract flow
    Isabel Wießner, Marcelo Falchi-Carvalho, Fernanda Palhano-Fontes, Lucas Oliveira Maia, Amanda Feilding, Sidarta Tollendal Gomes Ribeiro, Natália Bezerra Mota, Dráulio Barros de Araújo, Luís Fernando Tófoli · 2021 · Psychopharmacology
  24. Personality Traits in Former Spanish Substance Users Recovered with Ayahuasca
    Apud Peláez, Ismael Eduardo · 2020 · Journal of Psychoactive Drugs
  25. Moral Enhancement Should Target Self-Interest and Cognitive Capacity
    Rafael Ahlskog · 2017 · Neuroethics
  26. Inter-individual variability in neural response to low doses of LSD
    Nadia R. P. W. Hutten, Conny W.E.M. Quaedflieg, Natasha Leigh Mason, Eef Lien Theunissen, Matthias E. Liechti, Urs Duthaler, Kim P. C. Kuypers, Valérie Bonnelle, Amanda Feilding, Johannes Gerardus Ramaekers · 2024 · Translational Psychiatry
  27. Social identity processes as a vehicle for therapeutic success in psychedelic treatment
    Martha Newson, S. Alexander Haslam, Catherine Haslam, Tegan Cruwys, Leor Roseman · 2024 · Nature Mental Health
  28. Psychedelics and Psychedelic-Assisted Psychotherapy
    Collin M. Reiff, Elon E. Richman, Charles B. Nemeroff, Linda L. Carpenter, Alik S. Widge, Carolyn I. Rodríguez, Ned H. Kalin, William Maffitt McDonald · 2021 · FOCUS The Journal of Lifelong Learning in Psychiatry
  29. Greater empathy in MDMA users
    Molly Carlyle, Tobias Stevens, Leah Fawaz, Beth Marsh, Sophia Kosmider, Celia J. A. Morgan · 2019 · Journal of Psychopharmacology
  30. A longitudinal study of preadolescent and adolescent substance use: Within-individual patterns and protective factors
    Joaquín Rodríguez‐Ruiz, Izabela Zych, Vicente J. Llorent, Inmaculada Marín‐López · 2021 · International Journal of Clinical and Health Psychology
  31. Among psychedelic-experienced users, only past use of psilocybin reliably predicts nature relatedness
    Matthias Forstmann, Hannes Kettner, Christina Sagioglou, Alexander Irvine, Sam Gandy, Robin Lester Carhart-Harris, David P. Luke · 2023 · Journal of Psychopharmacology
  32. Who are you after psychedelics? A systematic review and a meta-analysis of the magnitude of long-term effects of serotonergic psychedelics on cognition/creativity, emotional processing and personality
    Ivana Solaja, Kate Haldane, Natasha Leigh Mason, Brandon Weiss, Xiaomin Xu, Mei Xu, Stevan Nikolin, Tharusha Jayasena, Michael Millard, Jonathan Brett et al. · 2024 · Neuroscience & Biobehavioral Reviews
  33. Neurotoxicology Syndromes Associated with Drugs of Abuse
    Rachel A. Caplan, Jonah P. Zuflacht, Jed A. Barash, Corey R. Fehnel · 2020 · Neurologic Clinics
  34. Neural and Genetic Correlates of the Social Sharing of Happiness
    Masahiro Matsunaga, Hiroaki Kawamichi, Tomohiro Umemura, Reiko Hori, Eiji Shibata, Fumio Kobayashi, Kohta Suzuki, Keiko Ishii, Yohsuke Ohtsubo, Yasuki Noguchi et al. · 2017 · Frontiers in Neuroscience
  35. Lysergic Acid Diethylamide (LSD) for the Treatment of Anxiety Disorders: Preclinical and Clinical Evidence
    Antonio Inserra, Alexandre Piot, Danilo De Gregorio, Gabriella Gobbi · 2023 · CNS Drugs
  36. Awake or Sleeping? Maybe Both… A Review of Sleep-Related Dissociative States
    Maria Eduarda Japyassu Sodré, Isabel Wießner, Muna Irfan, Carlos Hugh Schenck, Sergio Arthuro Mota-Rolim · 2023 · Journal of Clinical Medicine
  37. Examining the therapeutic effect of ceremonial ayahuasca on narcissistic personality and antagonistic externalizing in adults
    Weiss, Brandon, Sleep, Chelsea, Miller, Joshua D., Campbell, W. Keith · 2023 · Journal of Personality Disorders
  38. Psychedelic-Assisted Therapy and Psychedelic Science: A Review and Perspective on Opportunities in Neurosurgery and Neuro-Oncology
    Daniel F. Kelly, Keith G. Heinzerling, Akanksha Sharma, Shanthi Gowrinathan, Karina Sergi, Regin Jay Mallari · 2022 · Neurosurgery
  39. Disrupted Human–Dog Interbrain Neural Coupling in Autism‐Associated Shank3 Mutant Dogs
    Wei Ren, Shan Ping Yu, Kun Guo, Chunming Lu, Yongqing Zhang · 2024 · Advanced Science
  40. How to account for hallucinations in the interpretation of the antidepressant effects of psychedelics: a translational framework
    Manon van den Berg, Igor Magaraggia, Rudy Schreiber, Todd M. Hillhouse, Joseph H. Porter · 2022 · Psychopharmacology
  41. Entactogen Effects of Ketamine: A Reverse-Translational Study
    Evan M. Hess, Dede K. Greenstein, Olivia L. Hutchinson, Carlos A. Zarate, Todd D. Gould · 2024 · American Journal of Psychiatry
  42. The relation between naturalistic use of psychedelics and perception of emotional stimuli: An event-related potential study comparing non-users and experienced users of classic psychedelics
    Paweł Orlowski, Justyna Hobot, Anastasia Ruban, Jan Szczypiński, Michał Bola · 2023 · Journal of Psychopharmacology
  43. The Effects of Low Doses of Lysergic Acid Diethylamide in Healthy Humans: Demystifying the Microdosing of Psychedelics
    Katrin H. Preller · 2019 · Biological Psychiatry
  44. Interactive Effects of Ayahuasca and Cannabidiol in Social Cognition in Healthy Volunteers
    Giordano Novak Rossi, Juliana Mendes Rocha, Flávia de Lima Osório, José Carlos Bouso, Genís Oña, Gabriela de Oliveira Silveira, Maurı́cio Yonamine, Giuliana Bertozi, Eduardo José Crevelin, Maria Eugênia Costa Queiroz et al. · 2023 · Journal of Clinical Psychopharmacology
  45. The effects of Lysergic Acid Diethylamide (LSD) on the Positive Valence Systems: A Research Domain Criteria (RDoC)-Informed Systematic Review
    Niloufar Pouyan, Farnaz Younesi Sisi, Alireza Kargar, Milan Scheidegger, Roger S. McIntyre, Jonathan D. Morrow · 2023 · CNS Drugs
  46. Psychedelics and connectedness to natural and social worlds: An examination of the evidence and a proposed conceptual framework
    Matthias Forstmann, Christina Sagioglou · 2025 · Current Opinion in Psychology
  47. Role of Serotonin Transporter and Receptor Gene Variations in the Acute Effects of MDMA in Healthy Subjects
    Patrick Vizeli, Henriette E. Meyer zu Schwabedissen, Matthias E. Liechti · 2018 · ACS Chemical Neuroscience
  48. Present and future of metabolic and metabolomics studies focused on classical psychedelics in humans
    Francisco Madrid-Gambín, David Fabregat‐Safont, Àlex Gomez‐Gómez, Eulàlia Olesti, Natasha Leigh Mason, Johannes Gerardus Ramaekers, Óscar J. Pozo · 2023 · Biomedicine & Pharmacotherapy
  49. Research ethics aspects of experimentation with LSD on human subjects: a historical and ethical review
    János Kristóf Bodnár, Péter Kakuk · 2018 · Medicine Health Care and Philosophy
  50. Reported effects of psychedelic use on those with low well-being given various emotional states and social contexts
    Natasha Leigh Mason, Patrick C. Dolder, Kim P. C. Kuypers · 2020 · Drug Science Policy and Law
  51. Psychedelic medicines for mood disorders: current evidence and clinical considerations.
    Jerome J. Sarris, Diego Pinzon Rubiano, Kimberley Day, Nicole Leite Galvão Coelho, Daniel Perkins · 2022 · PubMed
  52. Altered States and Social Bonds: Effects of MDMA and Serotonergic Psychedelics on Social Behavior as a Mechanism Underlying Substance-Assisted Therapy
    Yasmin Schmid, Anya K. Bershad · 2024 · Biological Psychiatry Cognitive Neuroscience and Neuroimaging
  53. Psychedelic Therapy: A Primer for Primary Care Clinicians—Lysergic Acid Diethylamide (LSD)
    Bryce David Beutler, Kenneth Shinozuka, Burton Jared Tabaac, Alejandro Arenas, Kirsten N. Cherian, Viviana D. Evans, Chelsey Fasano, Owen S. Muir · 2024 · American Journal of Therapeutics
  54. Preclinical models for evaluating psychedelics in the treatment of major depressive disorder
    Laith Alexander, Dasha Anderson, Luke Baxter, Matthew D. B. Claydon, James Rucker, Emma S. J. Robinson · 2024 · British Journal of Pharmacology
  55. Increased functional connectivity between brain regions involved in social cognition, emotion and affective-value in psychedelic states induced by N,N-Dimethyltryptamine (DMT)
    Carla Soares, Gisela Lima, Marta Lapo Pais, Marta Teixeira, Célia Cabral, Miguel S. Castelo-Branco · 2024 · Frontiers in Pharmacology
  56. A Single Dose of LSD Does Not Alter Gene Expression of the Serotonin 2A Receptor Gene (HTR2A) or Early Growth Response Genes (EGR1-3) in Healthy Subjects
    Patrick C. Dolder, Edna Grünblatt, Felix Müller, Stefan Borgwardt, Matthias E. Liechti · 2017 · Frontiers in Pharmacology
  57. Microdosing psychedelics as cognitive and emotional enhancers.
    Ben David Rifkin, María J. Maraver, Lorenza S. Colzato · 2020 · Psychology of Consciousness Theory Research and Practice
  58. A Systematic Study of Microdosing Psychedelics
    Vince Polito, Richard James Stevenson · 2018
  59. Effects of classical psychedelics on implicit and explicit emotional empathy and cognitive empathy: a meta-analysis of MET task
    Amit Olami, Leehe Peled‐Avron · 2024 · Scientific Reports
  60. Classic psychedelics: the special role of the visual system
    Noémi Császár-Nagy, Gábor Kapócs, István Bókkon · 2019 · Reviews in the Neurosciences
  61. Advantages of analyzing postmortem brain samples in routine forensic drug screening—Case series of three non-natural deaths tested positive for lysergic acid diethylamide (LSD)
    Marie Mardal, Sys Stybe Johansen, Ragnar Thomsen, Kristían Línnet · 2017 · Forensic Science International
  62. Improved colour blindness symptoms associated with recreational psychedelic use: Results from the Global Drug Survey 2017
    JEC Anthony, ADAM R. WINSTOCK, Jason Ferris, David Nutt · 2020 · Drug Science Policy and Law
  63. Acute subjective effects of psychedelics in naturalistic group settings prospectively predict longitudinal improvements in trauma symptoms, trait shame, and connectedness among adults with childhood maltreatment histories
    C. J. Healy, Aaron Frazier, Stephen Kirsch, Anna Sanford, Albert Garcia‐Romeu, McWelling Todman, Jeremy Peter Varon, Wendy M. D'Andrea · 2025 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  64. Therapeutic Potential of Psychedelics in the Treatment of Psychiatric Disorders, Part 1
    Avinash Hosanagar, Joseph Michael Cusimano, Rajiv Radhakrishnan · 2021 · The Journal of Clinical Psychiatry
  65. Substance use to enhance occupational performance and experience: a critical interpretive synthesis
    Niki C. Kiepek, Brenda L. Beagan, Shanon Phelan · 2019 · Cadernos Brasileiros de Terapia Ocupacional
  66. Psychedelics and psychological strengths
    Trey J. Brasher, David Rosen, Marcello Spinella · 2023 · International Journal of Wellbeing
  67. Predictors Of Hallucinogen Persisting Perception Disorder Symptoms, Delusional Ideation And Magical Thinking Following Naturalistic Psychedelic Use
    Katie Zhou, David De Wied, Robin Lester Carhart-Harris, Hannes Kettner · 2022
  68. Psychedelic intimacy: Altered states of consciousness in romantic relationships
    Jonas J. Neubert, Katie Anderson, Natasha Leigh Mason · 2024 · Journal of Psychedelic Studies
  69. Serotonin Receptor ( HTR2A ) Gene Polymorphism Modulates Social Sharing of Happiness in Both American and Japanese Adults
    Masahiro Matsunaga, Yohsuke Ohtsubo, Takahiko Masuda, Yasuki Noguchi, Hidenori Yamasue, Keiko Ishii · 2021 · Japanese Psychological Research
  70. The potential role of lysergic acid diethylamide for psychological assisted therapy: A meta‐analysis of randomised controlled trials in healthy volunteers
    Hang Li, Yi Zhong, Siyuan Yang, Jiahe Wang, Xiang Li, Jianguo Xu, Heng Gao, Gang Chen · 2021 · Human Psychopharmacology Clinical and Experimental
  71. The zebrafish for preclinical psilocybin research
    Omer A. Syed, Benjamin Tsang, Robert T. Gerlai · 2023 · Neuroscience & Biobehavioral Reviews
  72. The effects of psilocybin on cognition and emotional processing in healthy adults and adults with depression: a systematic literature review
    Laura Ramos, Selene Vicente · 2024 · Journal of Clinical and Experimental Neuropsychology
  73. The influence of stakeholder interests on safety outcome reporting in psychedelic research and implications for science communication
    Elena Koning, Marco Solmi, Elisa Macedo Brietzke · 2024 · Trends in Psychiatry and Psychotherapy
  74. New Insights Into the Clinical and Nonclinical Effects of Psychedelic Substances
    Matthias Forstmann, Christina Sagioglou · 2021 · European Psychologist
  75. Independent elevation of peripheral oxytocin concentrations and reduction in cognitive empathy during 4‐fluoroamphetamine intoxication
    Patrick C. Dolder, Elizabeth B. de Sousa Fernandes Perna, Natasha Leigh Mason, Nadia R. P. W. Hutten, Stefan W. Toennes, Eef Lien Theunissen, Johannes Gerardus Ramaekers, Kim P. C. Kuypers · 2018 · Human Psychopharmacology Clinical and Experimental
  76. Advancing elite athlete mental health treatment with psychedelic-assisted psychotherapy
    Courtney Campbell Walton, Paul Liknaitzky · 2020 · Journal of Applied Sport Psychology
  77. Moving Forward by Looking Back
    Patrick Elf, Amy Isham, Dario Leoni · 2023 · History of Pharmacy and Pharmaceuticals
  78. Hemispheric annealing and lateralization under psychedelics (HEALS): A novel hypothesis of psychedelic action in the brain
    Adam W. Levin · 2024 · Journal of Psychopharmacology
  79. Ayahuasca-inspired DMT/HAR formulation reduces brain differentiation between self and other faces
    Dila Suay, Helena Aicher, Micheal Kometer, Michael J. Mueller, Luzia Caflisch, Alexandra Hempe, Camilla P. Steinhart, Claudius Elsner, Ilhui A Wicki, Jovin Müller et al. · 2025 · NeuroImage
  80. The emotional architecture of the psychedelic brain
    Flora Moujaes, Nathalie M. Rieser, L. Belinger, Marcus Herdener, Zarmeen Zahid, Katrin H. Preller · 2025 · Trends in Cognitive Sciences
  81. Effects of Acute Drug Administration on Emotion: A Review of Pharmacological MRI Studies
    Kathryne van Hedger, L. Mayo, A. Bershad, Racheal Madray, H. de Wit · 2021 · Current Addiction Report
  82. Neural Circuits Underlying Social Fear in Rodents: An Integrative Computational Model
    Valerio Alfieri, Andrea Mattera, Gianluca Baldassarre · 2022 · Frontiers in Systems Neuroscience
  83. Translation and Initial Psychometric Evaluation of Spanish Versions of Three Psychedelic Acute Effects Measures: Mystical, Challenging, and Insight Experiences
    Alan K. Davis, Christopher Timmermann, Ana María Ortiz Bernal, Rafael Lancelotta, Sandeep Manel Nayak, Nathan D. Sepeda, Aki Nikolaidis, Roland R. Griffiths · 2023 · Journal of Psychoactive Drugs
  84. Neurobiological Correlates of Psychedelic Experiences and Psychedelic-Associated Adverse Effects
    Nathalie M. Rieser, Timo Torsten Schmidt, Katrin H. Preller · 2024 · Current topics in behavioral neurosciences
  85. Psychedelics for Alcohol Use Disorder: A Narrative Review with Candidate Mechanisms of Action
    Eric A. Miller, Christy Capone, Erica M. Eaton, Robert M. Swift, Carolina L. Haass‐Koffler · 2025 · CNS Drugs
  86. From antidepressants and psychotherapy to oxytocin, vagus nerve stimulation, ketamine and psychedelics: how established and novel treatments can improve social functioning in major depression
    Aleksandra Kupferberg, Gregor Hasler · 2024 · Frontiers in Psychiatry
  87. Cognitive and affective models of psychedelics in rodents
    Dasha Anderson, Emma S. J. Robinson · 2025 · International review of neurobiology
  88. LSD: Mechanisms and relevance to the treatment of depression
    Amel Bouloufa, Sarah Delcourte, Thomas Delannay, Renaud Rovera, Thorsten Lau, Lionel Moulédous, Ouria Dkhissi‐Benyahya, Bruno Pierre Guiard, Nasser Haddjeri · 2025 · Neuroscience & Biobehavioral Reviews
  89. Understanding the Effects of Lysergic Acid Diethylamide and the Importance of Its Prevention
    Burak Okumuş, A. Metin, I. Kariper · 2023 · Health Sciences Review
  90. Exploring serotonergic psychedelics as a treatment for personality disorders
    Brennan M. Carrithers, Daniel E. Roberts, Brandon Weiss, Jacob D. King, Robin Lester Carhart-Harris, Alexandra R. Gordon, Broc A. Pagni, Miltiadis Moreau, Stephen Ross, Richard J. Zeifman · 2025 · Neuropharmacology
  91. Neurobiologische Grundlagen der Wirkung von Psychedelika
    Franz X. Vollenweider, Katrin H. Preller · 2017 · Springer eBooks
  92. God and the Problems of Love
    Kelly James Clark · 2023 · Cambridge University Press eBooks
  93. Understanding emotional empathy at postgraduate business programmes: what does the use of EEG reveal for future leaders?
    Steve Lambert, Nikolaos Dimitriadis, Michael Taylor, Matteo Venerucci · 2021 · Higher Education Skills and Work-based Learning
  94. Observer’s adrenal corticosterone secretion involvement in vicarious fear conditioning
    Yi‐Han Liao, Li-Han Sun, Ya-Hsuan Chan, Chienfang G. Cherng, Yi-Chi Su, Wei‐Jen Yao, Lung Yu · 2021 · Psychoneuroendocrinology
  95. Psychedelics and the future evolution of humanity
    Michael Winkelman · 2025 · Journal of Psychedelic Studies
  96. Effects of ayahuasca on fear and anxiety: cross-talk between 5HT1A and 5HT2A receptors
    Lorena Terene Lopes Guerra, R. D. dos Santos, J. E. Cecílio Hallak · 2024 · Psychedelics
  97. Neurotransmitter modulation of human facial emotion recognition
    Myrto Vlazaki, Catherine J. Harmer, Philip J. Cowen, Erdem Pulcu · 2025 · Journal of Psychopharmacology
  98. Acute and Long-Term Effects of Ayahuasca on (Higher-Order) Cognitive Processes
    Natasha Leigh Mason, Kim P. C. Kuypers · 2021 · Springer eBooks
  99. Measuring Emotions and Empathy in Educational Leadership
    Steve Lambert · 2022 · Advances in educational marketing, administration, and leadership book series
  100. Effects of LSD, DMT and psilocybin on cognitive and psychological functions: A systematic review of the literature
    Marten Kase, Kristjan Kaup, Jaan Aru · 2026 · Journal of Psychopharmacology